EU AI Act Applicability to US Insurers: Scoping Output Used in the EU and Evidencing Compliance
A US insurer with no EU establishment can still fall within the EU AI Act, because the Regulation is designed to reach providers and deployers established in third countries to prevent circumvention and protect people located in the Union. Whether a given system is in scope depends on a sequence of questions: is it an AI system, are its outputs used in the Union, what is your role, how is the use classified, and which obligations follow. Runtime policy enforcement can produce interaction-level evidence for part of that picture. It does not replace the legal analysis. This guide is educational and not legal advice.
A decision sequence for each use case
- 1
Is there an AI system?
List the systems, including those embedded in vendor platforms and internal copilots, and note which workflows they support.
- 2
Is there an EU nexus through output use?
For each system, trace where outputs go: EU-resident individuals, EU intermediaries, affiliates, or cross-border programs. Document who in the group makes this determination.
- 3
What is the role?
Decide whether you are the provider, the deployer, or both. A system built in-house and a system licensed from a vendor can lead to different answers.
- 4
What is the risk classification?
Test the use case against the Act's high-risk categories. Life and health insurance risk assessment and pricing for natural persons is the first place to look.
- 5
Which obligations follow?
Map the duties that attach to your role and class, including logging, human oversight, and record-keeping, to concrete controls.
What the regulation requires and what runtime controls can evidence
Why a US insurer can be in scope
The AI Act is Regulation (EU) 2024/1689. A recital explains the extraterritorial logic: to prevent circumvention of the Regulation and to ensure effective protection of natural persons located in the Union, the Regulation should also apply to providers and deployers of AI systems established in a third country. The test is therefore tied to where the effect of the system lands, not where the insurer is incorporated or where the model runs.
For carriers and brokerages, this matters because AI outputs travel through ordinary business processes. Underwriting or pricing for EU-resident policyholders, reinsurance and cross-border group programs, claims handling, and intermediary or affiliate workflows can all carry a US-hosted system's output to someone in the Union. None of these requires an EU office. Compliance teams should treat the absence of an EU establishment as irrelevant to the first screening question.
Provider, deployer, and the insurance use cases to test first
Role determination drives the obligation set, so it should be settled early and with primary-text review by counsel. In practice, an insurer that develops its own scoring model and puts it into use looks different from one that configures a third-party underwriting tool for its own staff. Group structures add complexity: an affiliate may build a system that another entity deploys. Capture the answer per system and per legal entity.
On classification, start with the use cases that decide outcomes for individuals. Risk assessment and pricing for natural persons in life and health insurance is the standard example. Claims handling, fraud screening, and customer-facing assistants deserve a documented classification decision too, even where the conclusion is that they fall outside the high-risk categories. A recorded rationale is more defensible than an assumption.
The main tradeoff is breadth versus precision. Treating every EU-touching system as high-risk is simple but expensive. Classifying narrowly reduces effort but depends on a well-supported nexus and classification record.
Timing as of November 2026
Some parts of the Act have applied since 2 August 2025, including the rules on governance structure, penalties, and obligations for providers of general-purpose AI model providers. Accountability provisions are therefore already live for in-scope operators, even where the high-risk rules are not yet the operative constraint.
On 19 November 2025 the Commission proposed targeted amendments known as the Digital Omnibus on AI. It would set fixed dates for the delayed application of the high-risk rules: 2 December 2027 for stand-alone high-risk AI systems and 2 August 2028 for high-risk systems embedded in products. These are proposed dates. Build your program plan so that it does not depend on a single date, and recheck the status of the proposal before committing to a deadline.
- 2 August 2025: Governance, penalty, and general-purpose AI model provider rules begin to apply.
- 19 November 2025: Commission proposes the Digital Omnibus on AI.
- 2 December 2027 (proposed): Application date for stand-alone high-risk AI systems under the proposal.
- 2 August 2028 (proposed): Application date for high-risk systems embedded in products under the proposal.
Where Trussed fits
Trussed is control, provenance, and evidence infrastructure for consequential AI, built for regulated enterprises that must show a regulator or auditor what their AI was allowed to do and what it did. It enforces policy in the execution path across models, agents, tools, MCP servers, AI sites, and coding assistants. Actions can be allowed, redacted, blocked, rate limited, or escalated for human approval. Enforcement is at runtime, not reviewed after the fact, and it applies to individual interactions and tool calls.
That enforcement generates continuous audit-ready evidence mapped to the EU AI Act, as well as NAIC, NYDFS, HIPAA, and NIST. For an insurer, this means the records of what a pricing assistant or claims tool was permitted to do and what it did come from the enforcement point itself. Deployment is self-managed in the customer cloud, with configurable retention and data residency.
The limits are plain. Trussed does not determine scope, role, or classification, and it does not provide model provenance, dataset lineage, or transaction-level governance across tasks and agents. It evidences enforcement at the interaction and tool-call level.
The scoping sequence
1. AI system
Confirm the tool is an AI system under the Act.
2. EU nexus
Test whether its outputs are used in the Union.
3. Role
Decide whether you act as provider, deployer, or both.
4. Risk class
Check the use case against the high-risk categories.
5. Obligations
Map duties to controls and to the evidence you can produce.
Review your EU-facing AI use cases against runtime evidence
Talk through how enforcement in the execution path produces audit-ready evidence for in-scope insurer AI systems.
Talk to an Expert